Key points are not available for this paper at this time.
Microplastic pollution is a growing global environmental and public health concern, driven by the increasing production and use of plastics. Due to their ubiquitous presence in the environment, humans and animals may be exposed to micro- and nanoplastics via several possible routes. For micro- and nanoplastics, the development of standardized and validated methods remains an important area of progress to support human health risk assessments. In order to monitor micro/nanoplastics’ occurrence in organisms and the environment, it is necessary to develop accurate and reliable methods to quantify and characterize micro/nanoplastics from various biological and environmental matrices. In this study, an analytical, multi-platform approach was established to characterize and quantify polystyrene nanoplastics in biological samples through a combination of sample pre-concentration, asymmetric flow field-flow fractionation, ultraviolet–visible light, dynamic light scattering detectors and pyrolysis–gas chromatography–mass spectroscopy. Several digestion methods on various rodent tissues were tested and modified, and these led to the development of tissue-specific protocols to maximize yield. These digestion protocols were then combined with a new method of concentrating and retaining plastics to prevent the loss of submicron particles. For identification and quantification, known amounts of polystyrene nanoplastics were spiked into rodent tissues (intestine, kidney and liver). This was followed up by a mouse in vivo study consisting of a single dose of PS-NPs, followed by tissue collection, digestion and analysis. Polystyrene particles were detected in the liver and kidney, but not reliably in the intestinal tissues.
Singh et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: